DEAN HAR: Open Payments
NPI 1104857150 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 31 payments from 8 companies in 2025. Trend: 2023 $1,832 · 2024 $2,268 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $470 |
| AstraZeneca Pharmaceuticals LP | 9 | $296 |
| ABBVIE INC. | 2 | $226 |
| Amgen Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60 |
| PFIZER INC. | 1 | $17 |
Products named: JARDIANCE, VRAYLAR, FARXIGA, Repatha, Ozempic, NEFFY, ZEPBOUND, BREZTRI.
Industry payments across CT — which companies pay providers there.
